Highlights the critical need for baseline cardiovascular risk assessment and larger multicenter trials to define effective cardioprotective strategies in oncology patients.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Macedo et al. (2022) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: